Intensity Therapeutics (INTS) Preferred Dividend Payments (2023)

Intensity Therapeutics' (INTS) quarterly Preferred Dividend Payments came in at $1.3 million in Q2 2023.

Intensity Therapeutics (INTS) Preferred Dividend Payments (2023) Analysis & Trends

Intensity Therapeutics (INTS) has 1 years of Preferred Dividend Payments data on file, last reported at $1.3 million in Q2 2023.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $1.3 million in Q2 2023, while the trailing twelve-month figure through Jun 2024 was $1.3 million (changed N/A YoY) and the FY2023 annual result came in at $1.3 million, changed N/A from the prior year.
Preferred Dividend Payments was little changed at $1.3 million in Q2 2023.
In the past five years, Preferred Dividend Payments ranged from a high of $1.3 million in Q2 2023 to a low of $1.3 million in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Intensity Therapeutics	13.06 Mn	13.06 Mn	-	-

Download Data

Date	Value
Jun 30, 2023	1.32 Mn